Kyle Amber to Psoriasis
This is a "connection" page, showing publications Kyle Amber has written about Psoriasis.
Connection Strength
2.591
-
Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340.
Score: 0.858
-
Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes. Arch Dermatol Res. 2022 Nov; 314(9):909-915.
Score: 0.742
-
Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524.
Score: 0.663
-
The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021 03; 30(3):304-318.
Score: 0.179
-
Conflict of interest in online point-of-care clinical support websites. J Med Ethics. 2014 Aug; 40(8):578-80.
Score: 0.112
-
Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunol Res. 2018 06; 66(3):425-430.
Score: 0.038